Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPAR: Premixed vs Basal-plus Insulin in Type 2 Diabetes
NCT02219750Phase 4Completed
- Sponsor
- Mackay Memorial Hospital
- Start
- Aug 2013
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of biphasic insulin aspart and insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Mackay Memorial Hospital. Started Aug 2013; status: completed.
02
Drugs
biphasic insulin aspartinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02219750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219750.